Rare lephants
Screener

Atossa Therapeutics, Inc.

ATOS ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
4 May 16, 2025 4
4 May 16, 2025 4
4 May 16, 2025 4
4 May 16, 2025 4
4 May 16, 2025 4
4 May 16, 2025 4
4 May 16, 2025 4
4 May 16, 2025 4
10-Q May 13, 2025 10-Q
8-K May 13, 2025 8-K
8-K May 12, 2025 8-K
8-K Apr 7, 2025 8-K
4 Mar 28, 2025 4
ARS Mar 26, 2025 ARS
DEF 14A Mar 26, 2025 DEF 14A
S-8 Mar 26, 2025 S-8
10-K Mar 25, 2025 10-K
8-K Mar 25, 2025 8-K
8-K Mar 12, 2025 8-K
8-K Feb 24, 2025 8-K
SCHEDULE 13G/A Feb 7, 2025
8-K Feb 4, 2025 8-K
8-K Dec 10, 2024 8-K
8-K Nov 19, 2024 8-K
424B5 Nov 19, 2024 424B5
← Newer Page 3 of 26 · 641 filings Older →